Robertson Stephens Wealth Management, LLC

Position in MRNA — Moderna, Inc.

CIK 1767307 San Francisco, CA

Position in MRNA

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$754,634

+$225,938 QoQ

Shares Held

14,855

-17.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Robertson Stephens Wealth Management, LLC holds $3,118,849 across 12 Biotechnology names. MRNA ranks #2 (24.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	2,836	$938,347
2	MRNA	Moderna, Inc. This page	14,855	$754,634
3	INCY	Incyte Corp	6,683	$629,003
4	SRPT	Sarepta Therapeutics, Inc.	11,023	$239,860
5	RLMD	Relmada Therapeutics, Inc.	25,000	$174,000
6	CUE	Cue Biopharma, Inc.	478,500	$110,055
7	ATAI	AtaiBeckley Inc.	28,297	$100,171
8	ACHV	Achieve Life Sciences, Inc.	20,000	$58,800

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$754,634	14,855	-17.1%	Shares	Sole	2026-04-28
2025-12-31	$528,696	17,928	+858.7%	Shares	Sole	2026-02-02
2023-03-31	$287,194	1,870	+15.4%	Shares	Sole	2023-05-11
2022-12-31	$290,984	1,620	-2.9%	Shares	Sole	2023-02-14
2022-06-30	$238,416	1,669	+1.5%	Shares	Sole	2022-08-12
2022-03-31	$283,367	1,645	0.0%	Shares	Sole	2022-05-16
2021-12-31	$417,797	1,645	+12.5%	Shares	Sole	2022-02-14
2021-09-30	$562,665	1,462	+30.5%	Shares	Sole	2021-11-10
2021-06-30	$263,177	1,120	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.